Geneos Wealth Management Inc. Increases Position in Oracle Corporation $ORCL

Geneos Wealth Management Inc. increased its position in shares of Oracle Corporation (NYSE:ORCL) by 36.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 29,070 shares of the enterprise software provider’s stock after acquiring an additional 7,732 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Oracle were worth $6,355,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of Oracle during the second quarter worth $4,275,378,000. Vanguard Group Inc. lifted its position in Oracle by 2.1% during the second quarter. Vanguard Group Inc. now owns 164,278,874 shares of the enterprise software provider’s stock worth $35,916,290,000 after buying an additional 3,353,461 shares during the period. Kingstone Capital Partners Texas LLC acquired a new stake in Oracle in the 2nd quarter worth about $731,512,000. Invesco Ltd. grew its holdings in Oracle by 42.1% in the 2nd quarter. Invesco Ltd. now owns 8,839,166 shares of the enterprise software provider’s stock valued at $1,932,507,000 after buying an additional 2,619,722 shares during the period. Finally, Assenagon Asset Management S.A. increased its stake in shares of Oracle by 840.7% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock valued at $463,380,000 after acquiring an additional 1,894,157 shares during the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.

Oracle Stock Down 4.6%

Shares of NYSE ORCL opened at $189.64 on Monday. The stock has a fifty day moving average price of $245.58 and a 200 day moving average price of $241.93. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28. Oracle Corporation has a 12-month low of $118.86 and a 12-month high of $345.72. The company has a market cap of $544.86 billion, a P/E ratio of 35.65, a P/E/G ratio of 1.82 and a beta of 1.66.

Oracle (NYSE:ORCL) last issued its quarterly earnings data on Wednesday, December 10th. The enterprise software provider reported $2.26 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.62. Oracle had a return on equity of 70.60% and a net margin of 25.28%.The company had revenue of $16.06 billion for the quarter, compared to analysts’ expectations of $16.19 billion. During the same quarter in the previous year, the firm posted $1.47 earnings per share. The firm’s quarterly revenue was up 14.2% on a year-over-year basis. Research analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 23rd. Shareholders of record on Friday, January 9th will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, January 9th. This represents a $2.00 annualized dividend and a yield of 1.1%. Oracle’s dividend payout ratio (DPR) is 37.59%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. decreased their target price on shares of Oracle from $270.00 to $230.00 and set a “neutral” rating on the stock in a research report on Thursday. Morgan Stanley increased their price target on shares of Oracle from $246.00 to $320.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 23rd. JMP Securities reiterated a “market outperform” rating and issued a $342.00 price target on shares of Oracle in a report on Friday, October 17th. Guggenheim reissued a “buy” rating and set a $400.00 price objective on shares of Oracle in a research note on Thursday. Finally, Robert W. Baird cut their target price on Oracle from $365.00 to $315.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 18th. Three analysts have rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, twelve have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $301.57.

Insider Buying and Selling

In other news, EVP Maria Smith sold 5,000 shares of Oracle stock in a transaction that occurred on Thursday, October 23rd. The shares were sold at an average price of $280.62, for a total transaction of $1,403,100.00. Following the sale, the executive vice president owned 47,083 shares in the company, valued at $13,212,431.46. This trade represents a 9.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeffrey Berg sold 49,365 shares of the company’s stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $283.02, for a total transaction of $13,971,282.30. Following the completion of the transaction, the director owned 151,999 shares of the company’s stock, valued at $43,018,756.98. This trade represents a 24.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 171,513 shares of company stock valued at $50,397,893 over the last three months. Company insiders own 40.90% of the company’s stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.